What You Should Know:
- Abbott, a global healthcare company, has announced the U.S. availability of Lingo, a continuous glucose monitoring (CGM) system designed for individuals who want to improve their overall health and wellness.
- Lingo is the first CGM available without a prescription designed for individuals who want to improve their overall health and wellness, regardless of whether they have diabetes.
A Powerful Tool for Health Management
Lingo combines a biosensor
Read More
Continuous Glucose Monitoring (CGM)
DexCom Launches Non-Prescription Glucose Biosensor in U.S.
What You Should Know:
- Millions of Americans with Type 2 diabetes and prediabetes now have a new option for managing their glucose levels.
- DexCom, a leader in continuous glucose monitoring (CGM) technology announced the launch of Stelo, the first over-the-counter (OTC) glucose biosensor available in the US.
What is Stelo?
Stelo is a small, wearable sensor that provides real-time glucose readings directly to a smartphone app. Unlike traditional blood glucose meters,
Read More
Abbott and Medtronic Partner to Integrate CGM System & Insulin Delivery Devices
What You Should Know:
- Abbott and Medtronic announced a groundbreaking partnership to develop an integrated continuous glucose monitoring (CGM) system designed to seamlessly work with Medtronic’s automated insulin delivery (AID) and smart insulin pen systems.
- The strategic collaboration aims to improve diabetes management by enabling more precise insulin dosing and reducing the burden on patients.
CGM System and Insulin Delivery Devices Integration
The new CGM sensor,
Read More
Abbott Unveils FreeStyle Libre 3 Plus: World’s Smallest CGM Sensor with Future AID Compatibility
What You Should Know:
- At the American Diabetes Association conference, Abbott unveiled a new addition to its FreeStyle Libre portfolio – the FreeStyle Libre 3 Plus sensor.
- The sensor boasts the distinction of being the world's smallest, thinnest, and most discreet continuous glucose monitoring (CGM) sensor available.
Unmatched Design and Performance
The FreeStyle Libre 3 Plus sensor offers a unique combination of user-centric features:
Unmatched Discreetness: The
Read More
CCS Unveils AI Predictive Model to Predict & Improves CGM Adherence in Diabetes Management
What You Should Know:
- CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — today announced PropheSee™ a new, AI-powered predictive model for healthcare organizations focused on improving adherence in the population of people that have been prescribed a continuous glucose monitoring (CGM) device to help manage their
Read More
Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
What You Should Know:
- Tandem Diabetes Care announced today that its Tandem Mobi insulin pump is fully compatible with Dexcom G6 and Dexcom G7 Continuous Glucose Monitoring (CGM) systems.
- Tandem is now the only company offering two insulin pump options integrated with both Dexcom G6 and Dexcom G7 CGM systems. This choice empowers people with diabetes to select the best solution for their individual needs and preferences.
Tandem Mobi: A Compact and Effective
Read More
Tandem Mobi Integrates with Dexcom G7 CGM, Expanding Choice for Diabetes Management
What You Should Know:
- Tandem Diabetes Care (TNDM) and Dexcom (DXCM) announced today that the Tandem Mobi insulin pump with Control-IQ technology is now compatible with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) systems.
- Overall, the Tandem Mobi and Dexcom G7 combination empowers people with diabetes with a discreet, convenient, and technologically advanced solution for managing their condition.
Tandem Mobi: Small Pump, Big Choice for Diabetes
Read More
MD Revolution & Dexcom Integrate Remote Glucose Monitoring
What You Should Know:
- MD Revolution, known for its remote care management solutions, collaborates with Dexcom to integrate cutting-edge continuous glucose monitoring systems into its platform.
- Dexcom, a global leader in real-time continuous glucose monitoring, serves over 537 million individuals worldwide living with diabetes. Through wearable devices synced with smartphones, patients' glucose data becomes accessible to clinicians via MD Revolution's care management platform,
Read More
Biolinq Secures $58M to Advance Continuous Glucose Monitoring Patch
What You Should Know:
- Biolinq, a provider of precision wearable biosensors for metabolic health secures $58M led by Alpha Wave Ventures. The round will include participation from Niterra’s corporate venture capital fund jointly operated with Pegasus Tech Ventures and existing investors RiverVest Venture Partners, AXA IM Alts, Global Health Investment Corporation, Aphelion Capital, Senvest Management, Features Capital and Taisho Pharmaceutical. J.P. Morgan served as a placement agent to
Read More
Know Labs Unveils KnowU: Wearable Non-Invasive CGM Poised to Revolutionize Glucose Monitoring
What You Should Know:
- Know Labs (NYSE American: KNW), a leading innovator in non-invasive medical diagnostic technology, today announced the unveiling of its KnowU™, a wearable, non-invasive continuous glucose monitor (CGM).
- With over 270 patents issued, pending, and in process, Know Labs has established a solid foundation for its technology, creating a competitive advantage in the non-invasive CGM landscape.
Wearable, Non-invasive Continuous Glucose Monitor
Just eight months
Read More
